PanOptix lens safety confirmed years after surgery

NCT ID NCT06166901

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at the long-term safety and performance of AcrySof PanOptix trifocal lenses in 211 people who had them implanted in both eyes 3 to 5 years earlier. Researchers checked vision and recorded any eye problems or device issues. The goal was to make sure these lenses remain safe and effective over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aphakia astigmatism cataract congenital primary aphakia presbyopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barraquer Ophthalmology Center

    Barcelona, 08021, Spain

  • Clinicas Novovision - Clinica Madrid

    Madrid, 28046, Spain

  • Hospital Arruzafa

    Córdoba, 14012, Spain

  • Hospital Universitari General de Catalunya

    Sabadell, Barcelona, 8205, Spain

  • Institut Catala de la Retina - Sarria

    Barcelona, 8022, Spain

  • Miranza IOA

    Madrid, 28033, Spain

  • Oftalvist Jerez - HLA Puerta del Sur

    Jerez de la Frontera, Cadiz, 11408, Spain